EX-99.2 4 ex-99d2.htm EX-99.2 waas_Ex99_2

Table of Contents

Exhibit 99.2

 

Pure Health Solutions, Inc.

 

Consolidated Financial Report

For the Nine-Month Period Ended

September 30, 2018

 

 


 


 

Pure Health Solutions, Inc.

Unaudited Consolidated Balance Sheets

September 30, 2018 and December 31, 2017

 

 

 

 

 

 

 

 

 

    

September 30,

    

December 31,

 

 

 

2018

 

2017

 

Assets

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash

 

$

507,112 

 

$

848,199 

 

Accounts receivable, net

 

 

1,383,576 

 

 

1,021,722 

 

Inventories, net

 

 

2,716,579 

 

 

1,790,827 

 

Prepaid expenses and other current assets

 

 

565,403 

 

 

435,096 

 

Current portion of deferred lease costs

 

 

799,097 

 

 

665,177 

 

Total current assets

 

 

5,971,767 

 

 

4,761,021 

 

Plant, property and equipment, net

 

 

1,207,815 

 

 

1,042,043 

 

Rental equipment, net

 

 

3,988,533 

 

 

3,132,560 

 

Holdback receivable

 

 

51,857 

 

 

51,857 

 

Deferred lease costs

 

 

1,888,147 

 

 

1,383,557 

 

Intangible assets, net

 

 

3,870,367 

 

 

4,805,303 

 

Total

 

$

16,978,486 

 

$

15,176,341 

 

 

(Continued)

 

1

 


 

Pure Health Solutions, Inc.

Unaudited Consolidated Balance Sheets (Continued)

September 30, 2018 and December 31, 2017

 

 

 

 

 

 

 

 

 

    

September 30,

    

December 31,

 

 

 

2018

 

2017

 

Liabilities and Stockholder's Equity (Deficit)

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Accounts payable

 

$

1,124,776 

 

$

587,596 

 

Amounts collected owed to third parties

 

 

59,919 

 

 

39,000 

 

Funding advance

 

 

147,478 

 

 

106,367 

 

Accrued compensation

 

 

855,255 

 

 

744,498 

 

Accrued expenses

 

 

805,370 

 

 

706,466 

 

Income tax payable

 

 

155,435 

 

 

93,738 

 

Current portion of deferred rental revenue, net

 

 

4,512,939 

 

 

3,656,192 

 

Other current liabilities

 

 

53,028 

 

 

39,013 

 

Total current liabilities

 

 

7,714,200 

 

 

5,972,870 

 

Long-term liabilities:

 

 

 

 

 

 

 

Related-party notes payable

 

 

21,766,417 

 

 

19,500,417 

 

Related-party liabilities

 

 

11,536,173 

 

 

9,433,641 

 

Deferred rental revenue, net

 

 

9,735,545 

 

 

7,678,390 

 

Deferred income taxes

 

 

660,797 

 

 

875,006 

 

Other long-term liabilities

 

 

106,162 

 

 

90,690 

 

Total long-term liabilities

 

 

43,805,094 

 

 

37,578,144 

 

Total liabilities

 

 

51,519,294 

 

 

43,551,014 

 

Commitments (Note 9)

 

 

 

 

 

 

 

Stockholder's equity (deficit):

 

 

 

 

 

 

 

Common stock (no par value), 5,000,000 shares authorized; 1,000,000 shares issued and outstanding at amount paid in

 

 

33,236,834 

 

 

33,236,834 

 

Accumulated deficit

 

 

(67,777,642)

 

 

(61,611,507)

 

Total stockholder's equity (deficit)

 

 

(34,540,808)

 

 

(28,374,673)

 

Total

 

$

16,978,486 

 

$

15,176,341 

 

 

See notes to unaudited consolidated financial statements.

2

 


 

Pure Health Solutions, Inc.

Unaudited Consolidated Statements of Operations

Nine-Month Periods Ended September 30, 2018 and 2017

 

 

 

 

 

 

 

 

 

    

Nine-Month

    

Nine-Month

 

 

 

Period Ended

 

Period Ended

 

 

 

September 30,

 

September 30,

 

 

 

2018 

 

2017 

 

Net sales

 

$

10,142,374 

 

$

9,944,122 

 

Rental income

 

 

5,499,815 

 

 

4,378,633 

 

Other revenues

 

 

442,575 

 

 

484,417 

 

Total revenue

 

 

16,084,764 

 

 

14,807,172 

 

Cost of goods sold:

 

 

 

 

 

 

 

Net sales

 

 

4,890,069 

 

 

4,940,407 

 

Rental income

 

 

1,737,223 

 

 

1,464,242 

 

Other revenues

 

 

72,588 

 

 

101,592 

 

Total cost of goods sold

 

 

6,699,880 

 

 

6,506,241 

 

Gross profit

 

 

9,384,884 

 

 

8,300,931 

 

Operating expenses:

 

 

 

 

 

 

 

Selling, general and administrative

 

 

12,956,777 

 

 

11,361,270 

 

Operating loss

 

 

(3,571,893)

 

 

(3,060,339)

 

Other expenses:

 

 

 

 

 

 

 

Interest expense, net

 

 

2,765,895 

 

 

2,196,365 

 

Other, net

 

 

(23,025)

 

 

48,743 

 

 

 

 

2,742,870 

 

 

2,245,108 

 

Net loss before income taxes

 

 

(6,314,763)

 

 

(5,305,447)

 

Income tax (benefit)

 

 

(148,628)

 

 

(247,968)

 

Net loss

 

$

(6,166,135)

 

$

(5,057,479)

 

 

See notes to unaudited consolidated financial statements.

 

3

 


 

Pure Health Solutions, Inc.

Unaudited Consolidated Statements of Stockholder's Equity (Deficit)

Nine-Month Periods Ended September 30, 2018 and 2017

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stock

 

Accumulated

 

 

 

 

    

Shares

    

Amount

    

Deficit

    

Total

 

Stockholder's equity (deficit) balance, January 1, 2017

 

1,000,000 

 

$

33,036,834 

 

$

(54,795,258)

 

$

(21,758,424)

 

Net loss

 

— 

 

 

— 

 

 

(5,057,479)

 

 

(5,057,479)

 

Stockholder's equity (deficit), September 30, 2017

 

1,000,000 

 

$

33,036,834 

 

$

(59,852,737)

 

$

(26,815,903)

 

Stockholder's equity (deficit), January 1, 2018

 

1,000,000 

 

$

33,236,834 

 

$

(61,611,507)

 

$

(28,374,673)

 

Net loss

 

— 

 

 

— 

 

 

(6,166,135)

 

 

(6,166,135)

 

Stockholder's equity (deficit), September 30, 2018

 

1,000,000 

 

$

33,236,834 

 

$

(67,777,642)

 

$

(34,540,808)

 

 

See notes to unaudited consolidated financial statements.

 

4

 


 

Pure Health Solutions, Inc.

Unaudited Consolidated Statements of Cash Flows

Nine-Month Periods Ended September 30, 2018 and 2017

 

 

 

 

 

 

 

 

 

    

Nine-Month

    

Nine-Month

 

 

 

Period Ended

 

Period Ended

 

 

 

September 30,

 

September 30,

 

 

 

2018  

 

2017  

 

Cash flows from operating activities:

 

 

 

 

 

 

 

Net loss

 

$

(6,166,135)

 

$

(5,057,479)

 

Adjustments to reconcile net loss to net cash flows used in operating activities:

 

 

 

 

 

 

 

Depreciation and amortization of property, plant and equipment

 

 

143,914 

 

 

113,995 

 

Depreciation of rental equipment

 

 

617,983 

 

 

480,553 

 

Amortization of intangible assets

 

 

934,936 

 

 

934,936 

 

Amortization of deferred lease costs

 

 

588,480 

 

 

459,573 

 

Loss on sale of rental equipment

 

 

89,100 

 

 

— 

 

Non-cash interest on related-party liabilities

 

 

1,802,532 

 

 

1,428,394 

 

Holdback receivable

 

 

— 

 

 

551,642 

 

Deferred revenue

 

 

(2,085,578)

 

 

(2,886,404)

 

Deferred income taxes

 

 

(214,209)

 

 

(317,318)

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

Accounts receivable

 

 

(361,854)

 

 

(93,611)

 

Inventories

 

 

(925,752)

 

 

(690,456)

 

Prepaid expenses, deferred lease costs and other current assets

 

 

(1,357,297)

 

 

(800,553)

 

Accounts payable

 

 

537,180 

 

 

186,421 

 

Accrued expenses, related-party liabilities and other liabilities

 

 

560,067 

 

 

(382,784)

 

Proceeds from operating leases

 

 

4,999,480 

 

 

4,049,173 

 

Income tax payable

 

 

61,697 

 

 

— 

 

Net cash flows used in operating activities

 

 

(775,456)

 

 

(2,023,918)

 

Cash flows from investing activities:

 

 

 

 

 

 

 

Purchases of property, plant and equipment

 

 

(309,686)

 

 

(101,266)

 

Purchases of rental equipment

 

 

(1,563,056)

 

 

(982,087)

 

Net cash flows used in investing activities

 

 

(1,872,742)

 

 

(1,083,353)

 

Cash flows from financing activities:

 

 

 

 

 

 

 

Restricted cash

 

 

— 

 

 

41,535 

 

Proceeds from issuance of related-party notes payable

 

 

2,266,000 

 

 

2,510,076 

 

Proceeds (payments) from funding advance

 

 

41,111 

 

 

(56,955)

 

Net cash flows provided by financing activities

 

 

2,307,111 

 

 

2,494,656 

 

Decrease in cash and cash equivalents

 

 

(341,087)

 

 

(612,615)

 

Cash and cash equivalents - beginning of period

 

 

848,199 

 

 

1,336,139 

 

Cash - end of period

 

$

507,112 

 

$

723,524 

 

Supplemental cash flow disclosures:

 

 

 

 

 

 

 

Income taxes paid

 

$

— 

 

$

— 

 

Interest paid

 

$

963,363 

 

$

767,971 

 

 

See notes to unaudited consolidated financial statements.

 

 

 

5

 


 

Table of Contents

Pure Health Solutions, Inc.

Notes to Unaudited Consolidated Financial Statements

 

Note 1.Nature of Business and Summary of Significant Accounting Policies

Nature of business:  Pure Health Solutions, Inc. (PHSI or the Company) was incorporated in 1996 under the laws of Idaho and is located in Lincolnshire, Illinois. The primary business of the Company is the manufacturing and sale of state-of-the art drinking water purification systems. Enstar, a wholly-owned Korean subsidiary, manufactures the Company's water purifiers, which it sells to the Company and to customers throughout Asia and Europe. Sales from foreign operations were approximately $233,000 and $259,000 for the nine-month periods ended September 30, 2018 and 2017, respectively. The Company sells the water purifiers to a network of dealers throughout the United States and sells or leases its water purifiers directly to national account customers and also to local small business customers through its branch operations in Illinois, California, Texas, Indiana, Missouri and Ohio. The Company also sells coffee and related products through an online store. A portion of the Company's revenues results from financing transactions involving the purchase of lease contracts from dealers and the sale of those contracts to independent financing companies.

 

Basis of presentation: The unaudited consolidated financial statements have been prepared pursuant to the rules and regulations of interim financial reporting.  These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto included in the Company's December 31, 2017, consolidated financial statements. In management's opinion, the accompanying unaudited consolidated financial statements reflect all adjustments (consisting of only normal recurring adjustments) considered necessary for a fair presentation of the Company's unaudited consolidated balance sheet as of September 30, 2018, and the unaudited consolidated statements of operations for the nine months ended September 30, 2018 and 2017. The consolidated balance sheet as of December 31, 2017, was based on the audited consolidated balance sheet as of December 31, 2017, as presented in the Company's December 31, 2017, consolidated financial statements.

 

Principles of consolidation: The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All material intercompany accounts and transactions are eliminated in consolidation.

 

Use of estimates: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates.

 

Cash:  The Company maintains cash in bank deposit accounts, which at times may exceed the federally insured limits. The Company and its subsidiaries have not experienced any losses in bank accounts and management believes the Company is not exposed to any significant credit risk on cash deposits. As of September 30, 2018 and December 31, 2017, cash in foreign bank accounts amounts to approximately $427,000 and $85,000, respectively.

 

Receivables: Trade accounts receivable are carried at the original invoice amount less an estimate made for doubtful receivables. Management determines the collectability of accounts by regularly evaluating individual customer receivables and considering a customer’s financial condition, credit history, and current economic conditions. Recoveries of trade receivables previously written off are recorded when received. The allowance for doubtful accounts was approximately $163,000 and $140,000 as of September 30, 2018 and December 31, 2017, respectively.

 

Inventories: Inventories are stated at the lower of cost (first-in, first-out basis) or net realizable value as of September 30, 2018 and December 31, 2017. Inventories of finished goods are manufactured only on current models requiring no general reserve for slow-moving or obsolete inventory. As of September 30, 2018 and

6

 


 

Table of Contents

Pure Health Solutions, Inc.

Notes to Unaudited Consolidated Financial Statements

 

December 31, 2017, the Company had reserves for slow-moving or obsolete parts and filters amounting to approximately $249,000 and $303,000, respectively.

 

Deferred lease costs:  When a customer enters into a lease agreement with the Company the direct lease costs to initiate the lease are paid in cash, which primarily consist of sales commissions. The Company has the right to reimbursement of the sales commissions paid in cash if the customer defaults on their payments or if the employee leaves the Company. The Company capitalizes the sales commissions paid to deferred lease costs, as these costs are directly related to initiating the lease. The capitalized commissions are then expensed over the term of the lease. The current portion represents the amount of deferred lease costs to be expensed in the following year. For equipment sales the entire commissions are expensed when paid.

 

Property, plant and equipment: Property, plant and equipment are carried at cost less accumulated depreciation. Depreciation is computed over the assets’ estimated useful lives using straight-line methods. Asset lives range from 2 to 15 years. Assets related to leasehold improvements are amortized at the lesser of the life of the lease or useful life of the asset.

 

Rental equipment: Rental equipment represents the leased purifiers for which the Company has retained title (see Note 2). The Company depreciates the rental equipment over the lease term, which typically ranges between 3 and 5 years.

 

Intangible assets: Intangible assets are comprised of customer lists, patents and trade names with estimated useful lives between 3 and 15 years. Intangible assets are amortized over their estimated lives using the straight-line method.

 

Impairment of long-lived assets: Long-lived assets are evaluated for impairment whenever events or changes in circumstances have indicated that an asset may not be recoverable and are grouped with other assets to the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. If the sum of the projected undiscounted cash flows (excluding tax and interest charges) is less than the carrying value of the assets, the assets will be written down to the estimated fair value and such loss is recognized in income from continuing operations in the period in which the determination is made. Management determined that no impairment of long-lived assets existed as of September 30, 2018 and December 31, 2017.

 

Revenue recognition:

Net sales: Sales are recognized when revenue is realized or realizable and has been earned. Most revenue transactions represent sales of inventory (equipment, filters, parts and freight) and are recognized when the product is shipped, net of any associated discounts. The revenue recorded is presented net of sales discounts and other taxes and amounted to approximately $10,142,000 and $9,089,000 for the nine-month periods ended September 30, 2018 and 2017, respectively.

 

Rental income: The Company enters into certain lease arrangements with national accounts and local small business accounts which are accounted for as operating leases (see Note 9). Rental income from leases is recorded when earned and amounted to approximately $5,500,000 and $4,400,000 for the nine-month periods ended September 30, 2018 and 2017, respectively. When the Company receives upfront proceeds for the lease arrangements, the proceeds are recorded as deferred rental revenue on the unaudited consolidated balance sheets (see Note 9).

 

Other revenues: The Company purchases certain lease contracts from third-party dealers and transfers those assets to an independent financing company. The difference between the rates charged to the third-party dealers and the rates charged by the independent financing company is recorded as finance revenue. Revenue from the dealers’ nominal lease residual option payment is recognized when invoiced at lease

7

 


 

Table of Contents

Pure Health Solutions, Inc.

Notes to Unaudited Consolidated Financial Statements

 

maturity. In addition, other revenue includes service fees, late fees and other miscellaneous fees charged to customers. Total other revenue amounted to approximately $443,000 and $484,000 for the nine-month periods ended September 30, 2018 and 2017, respectively.

 

Advertising: Advertising and marketing costs are charged to expense as incurred and totaled approximately $350,000 and $165,000 for the nine-month periods ended September 30, 2018 and 2017, respectively.

 

Shipping costs: The costs of shipping relating to purchases and sales of products are included in cost of goods sold in the accompanying unaudited consolidated statements of operations.

 

Income taxes: Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more-likely-than-not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

 

Investment tax credits are accounted for by the flow-through method whereby they reduce income taxes currently payable and the provision for income taxes in the period the assets giving rise to such credits are placed in service. To the extent such credits are not currently utilized on the Company's tax return, deferred tax assets, subject to considerations about the need for a valuation allowance, are recognized for the carry-forward amount.

 

The Company recognizes the tax benefit from an uncertain tax position only if it is more-likely-than-not that the tax position will be sustained on examination by taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement. The amount of unrecognized tax benefits is adjusted as appropriate for changes in facts and circumstances, such as significant amendments to existing tax law, new regulations or interpretations by the taxing authorities, new information obtained during a tax examination, or resolution of an examination.

 

Foreign currency transactions:  The functional currency for Enstar is the U.S. dollar.  Assets and liabilities of foreign operations have been translated to U.S. dollars using year-end exchange rates or historical rates. Income and expense accounts have been translated to U.S. dollars using average exchange rates. Gains and losses from foreign currency transactions are included in determining net income. The foreign currency transactions resulted in a loss of approximately $68,000 and $57,000 for the nine-month periods ended September 30, 2018 and 2017, respectively. The foreign currency transactions are recorded within other expenses on the unaudited consolidated statements of operations.

 

Recent accounting pronouncements:

Revenue recognition:

In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, Revenue from Contracts with Customers (Topic 606), requiring an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The updated standard will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective and permits the use of either a full retrospective or retrospective with cumulative effect transition method. In August 2015, the FASB issued ASU 2015-14, which defers the effective date of ASU 2014-09 one year, making it effective for annual reporting periods beginning after December 15, 2018. Earlier application is permitted. The Company has not yet selected a transition method and is currently evaluating the effect that the standard will have on the unaudited consolidated financial statements.

8

 


 

Table of Contents

Pure Health Solutions, Inc.

Notes to Unaudited Consolidated Financial Statements

 

 

Leases:

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). The guidance in this ASU supersedes the leasing guidance in Topic 840, Leases. Under the new guidance, lessees and lessors are required to recognize lease assets and lease liabilities on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. The new standard is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The Company is currently evaluating the impact of the pending adoption of the new standard on the unaudited consolidated financial statements.

 

Cash flows:

In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (a consensus of the FASB Emerging Issues Task Force). This ASU requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. ASU 2016-18 is effective for financial statements issued for annual periods beginning after December 15, 2018. Early adoption is permitted, and this ASU requires it to be applied retrospectively to all periods presented. The Company has not yet adopted this ASU in the current year and is currently evaluating the impact of the pending adoption of the new standard on the unaudited consolidated financial statements.

 

Subsequent events: The Company has evaluated subsequent events through the date the financial statements were available to be issued.

 

On December 18, 2018, 100 percent of the Company’s stockholder’s equity was acquired by AquaVenture Holdings Limited for an approximate purchase price of $58,800,000. As a result of the acquisition, all of the Company’s related-party notes payable and liabilities disclosed in Note 8 were settled in full.

 

Note 2.Financing Arrangements

 

The Company sells water purifiers to dealers who enter into long-term contracts (usually three to five years) for leasing of water purifiers to their customers. Dealers that elect to sell their lease contracts to the Company may do so under the Company’s Dealer Financing Agreement (the Agreement). Under the Agreement, the Company may purchase the dealers’ lease contracts at a discounted cash settlement price. The Company typically exercises their right to purchase only when they have credit approval for the purchase of the lease contract from independent financing companies. The Company obtains title to the leased purifiers as part of the agreement. The title is immediately transferred or assigned to an independent financing company until the end of the lease term and the Company receives the cash proceeds from the independent financing company upon transferring the title. The dealers have an option to purchase the leased purifiers from the Company upon the expiration of the related leases for a nominal amount. Revenue from the dealers’ nominal lease residual option payment is recognized when invoiced at lease maturity.

 

These receivables are accounted for under Accounting Standards Codification (ASC) 860, Transfers and Servicing, whereby the Company recognizes financial assets it controls and the liabilities it has incurred and derecognizes financial assets when control has been surrendered. Under ASC 860, control is considered to have been surrendered only if (i) the transferred financial assets have been isolated from the transferor and its creditors, even in bankruptcy or other receivership, (ii) the transferee has the right to pledge or exchange

9

 


 

Table of Contents

Pure Health Solutions, Inc.

Notes to Unaudited Consolidated Financial Statements

 

the transferred financial assets it received, and (iii) the transferor does not maintain effective control over the transferred financial assets through an agreement that both entitles and obligates it to repurchase or redeem those assets prior to maturity, through an agreement that provides the transferor the unilateral ability to cause the holder to return specific financial assets and a more-than-trivial benefit attributable to that ability, or an agreement that permits the transferee to require the transferor to repurchase the transferred financial assets at a price that is so favorable to the transferee that it is probable that the transferee will require repurchase. The Company has determined that these receivables qualify for sales treatment and, accordingly, the purchases and proceeds are included in net cash flows provided by financing activities in the unaudited consolidated statements of cash flows.

 

Finance income, included in other revenues in the accompanying unaudited consolidated statements of operations, totaled approximately $210,000 and $252,000 for the nine-month periods ended September 30, 2018 and 2017, respectively.

 

As part of a  previous funding arrangement, 5 percent of the selected proceeds on the transfers of assets were retained by the financing company until all receivables had been collected. These amounts are included on the unaudited consolidated balance sheets as holdback receivables and are reported net of allowance for losses of $51,587 as of September 30, 2018 and December 31, 2017, respectively.

 

Note 3.Inventories

 

Inventories at September 30, 2018 and December  31, 2017,  consist of the following:

 

 

 

 

 

 

 

 

 

 

    

September 30,

    

December 31,

 

 

 

2018 

 

2017 

 

Raw materials

 

$

542,789 

 

$

300,071 

 

Finished goods

 

 

1,447,866 

 

 

867,738 

 

Parts and filters, net

 

 

725,924 

 

 

623,018 

 

 

 

$

2,716,579 

 

$

1,790,827 

 

 

 

Note 4.Property, Plant and Equipment

 

Property, plant and equipment at September 30, 2018 and December 31, 2017,  consist of the following:

 

 

 

 

 

 

 

 

 

 

    

September 30,

    

December 31,

 

 

 

2018

 

2017 

 

Land

 

$

560,454 

 

$

560,454 

 

Buildings and improvements

 

 

695,865 

 

 

675,049 

 

Machinery and tools

 

 

1,301,233 

 

 

1,311,166 

 

Vehicles

 

 

438,102 

 

 

368,025 

 

Furniture and fixtures

 

 

341,588 

 

 

335,270 

 

Software

 

 

742,760 

 

 

519,383 

 

 

 

 

4,080,002 

 

 

3,769,347 

 

Less: accumulated depreciation

 

 

(2,872,187)

 

 

(2,727,304)

 

 

 

$

1,207,815 

 

$

1,042,043 

 

 

Depreciation expense for the nine-month periods ended September 30, 2018 and 2017, was approximately $144,000 and $114,000,  respectively.

 

10

 


 

Table of Contents

Pure Health Solutions, Inc.

Notes to Unaudited Consolidated Financial Statements

 

Note 5.Rental Equipment

 

Rental equipment as of September 30, 2018 and December 31, 2017, consists of the following:

 

 

 

 

 

 

 

 

 

 

    

September 30,

    

December 31,

 

 

 

2018 

 

2017 

 

Rental equipment

 

$

6,406,269

 

$

4,932,308

 

Less: accumulated depreciation

 

 

(2,417,736)

 

 

(1,799,748)

 

 

 

$

3,988,533

 

$

3,132,560

 

 

Depreciation expense for the nine-month periods ended September 30, 2018 and 2017,  was approximately $618,000 and $481,000,  respectively.

 

Note 6.Intangible Assets

 

As of September 30, 2018 and December 31, 2017, intangible assets consist of the following:

 

 

 

 

 

 

 

 

 

 

 

 

    

Estimated

    

September 30,

    

December 31,

 

 

 

Useful Life

 

2018 

 

2017 

 

Trademarks and tradenames

 

15 years

 

$

2,784,644 

 

$

2,784,644 

 

Customer relationships

 

8-15 years

 

 

7,489,100 

 

 

7,489,100 

 

Patents and technology

 

10 years

 

 

4,818,400 

 

 

4,818,400 

 

Noncompete agreements

 

1-3 years

 

 

1,700,000 

 

 

1,700,000 

 

 

 

 

 

 

16,792,144 

 

 

16,792,144 

 

Less: accumulated amortization

 

 

 

 

(12,921,777)

 

 

(11,986,841)

 

 

 

 

 

$

3,870,367 

 

$

4,805,303 

 

 

Amortization expense for both of the nine-month periods ended September 30, 2018 and 2017, was approximately $935,000. Estimated amortization expenses related to intangible assets for the period from October 1, 2018 to December 31, 2018 and for future fiscal years ending December 31 are as follows:

 

 

 

 

 

 

Years ending December 31,

    

    

 

2018

 

$

311,646 

 

2019

 

 

991,027 

 

2020

 

 

541,027 

 

2021

 

 

506,667 

 

2022

 

 

506,667 

 

Thereafter

 

 

1,013,333 

 

 

 

Note 7.Income Taxes

 

Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes related to temporary differences between the basis of lease servicing cost, acquired intangibles, warranty allowance, and lease residuals for financial and income tax reporting. The deferred tax assets and liabilities represent the future tax return consequences of those differences which will either be taxable or deductible when the assets and liabilities are recovered or settled. No U.S. income tax liability or asset is provided on undistributed earnings or losses of the Company’s foreign subsidiaries. The earnings of the foreign subsidiaries, which reflect provisions for foreign taxes when applicable, are currently indefinitely reinvested in the foreign operations or will be remitted substantially free of additional tax.

11

 


 

Table of Contents

Pure Health Solutions, Inc.

Notes to Unaudited Consolidated Financial Statements

 

 

The provision for income taxes charged to operations for the nine-month periods ended September 30, 2018 and 2017, consists of the following:

 

 

 

 

 

 

 

 

 

 

    

September 30,

    

September 30,

 

 

 

2018 

 

2017 

 

Income tax expense (benefit):

 

 

 

 

 

 

 

State

 

$

3,885 

 

$

5,382 

 

Deferred

 

 

(214,209)

 

 

(317,318)

 

Non-U.S.

 

 

61,696 

 

 

63,950 

 

Total income tax (benefit)

 

$

(148,628)

 

$

(247,986)

 

 

On December 22, 2017, the Tax Cuts and Jobs Act tax reform legislation was signed into law. This legislation made significant changes to the U.S. tax law including a reduction in the corporate tax rates, changes to net operating loss carryforwards and carrybacks, and a repeal of the corporate alternative minimum tax. The law was required to be accounted for in the period of enactment, which for the Company was January 1, 2018. The legislation reduced the U.S. corporate tax rate from 35 percent to 21 percent. The income taxes for the nine-month period ended September 30, 2017, were subject to the U.S. corporate tax rate of 35 percent.

 

Note 8.Related-Party Notes Payable, Related-Party Transactions and Subsequent Events

 

Debt consists of the following at September 30, 2018 and December 31, 2017:

 

 

 

 

 

 

 

 

 

 

    

September 30,

    

December 31,

 

 

 

2018 

 

2017 

 

Note payable - Related party A

 

$

21,567,448 

 

$

19,301,448 

 

Note payable - Related party B

 

 

120,743 

 

 

120,743 

 

Note payable - Related party C

 

 

49,857 

 

 

49,857 

 

Note payable - Related party D

 

 

28,369 

 

 

28,369 

 

 

 

$

21,766,417 

 

$

19,500,417 

 

 

The Company had notes payable with four shareholders of the Company’s parent. The notes payable were scheduled to mature on December 31, 2019, and accrued interest at 10 percent annually with both principal and interest due at maturity. The notes payable were secured by substantially all assets of the Company. As discussed further in Note 1 to the unaudited consolidated financial statements, the notes payable were paid off subsequent to September 30, 2018.

 

Total interest accrued on the notes as of September 30, 2018 and December 31, 2017,  amounted to $8,889,156 and $7,311,952, respectively, and is included in related-party liabilities on the unaudited consolidated balance sheets.

 

The Company had an annual management fee to CLP of $400,000 plus interest on the unpaid portion. As of September 30, 2018 and December 31, 2017,  the Company had accrued management fees of $2,647,017 and $2,121,689, respectively, which are included in related-party liabilities on the unaudited consolidated balance sheets.

 

Note 9.Commitments

 

The Company enters into operating leases with local small businesses and targeted national accounts to supply products and services, which generally have initial lease terms of 36-60 months. These operating

12

 


 

Table of Contents

Pure Health Solutions, Inc.

Notes to Unaudited Consolidated Financial Statements

 

leases are used as collateral to secure funding with a financing company. The Company accounts for the cash proceeds from the proceeds as deferred revenue on the unaudited consolidated balance sheets, which is amortized using the effective interest method over the life of the lease contracts. The Company obtained cash proceeds from operating leases in the amounts of $4,999,480 and $4,049,173 for the nine-month periods ended September 30, 2018 and 2017, respectively. The deferred revenues are recorded on the unaudited consolidated balance sheets at the present value of lease commitments. Customer payments on the operating leases are used to repay the financing company.

 

A portion of the monthly rental payments paid to the financing company represent interest expense incurred by the Company associated with the funding and advance proceeds received. The Company’s interest expense for the nine-month periods ended September 30, 2018 and 2017, was $958,012 and $770,145, respectively.

 

The total liability balance of the deferred rental revenue related to the operating leases was $14,248,484 and $11,334,582 as of September 30, 2018 and December 31, 2017, respectively. The following table represents the expiration year of leases on the total deferred rental revenue liability as of September 30, 2018, for leases expiring during the period from October 1, 2018 to December 31, 2018 and in future fiscal years ending December 31:

 

 

 

 

 

2018

    

$

5,860 

2019

 

 

474,235 

2020

 

 

1,128,394 

2021

 

 

2,707,288 

2022

 

 

4,383,850 

Thereafter

 

 

5,548,857 

 

 

$

14,248,484 

 

Future rental income on operating leases to be recorded by the Company totals $18,711,081 as of September 30, 2018. The following table represents the expiration year of leases and the total rental income to be recorded over the life of such leases expiring during the period from October 1, 2018 to December 31, 2018 and future fiscal years ending December 31:

 

 

 

 

 

2018

    

$

7,590 

2019

 

 

621,293 

2020

 

 

1,456,806 

2021

 

 

3,511,681 

2022

 

 

5,772,859 

Thereafter

 

 

7,340,852 

 

 

$

18,711,081 

 

 

13